785 related articles for article (PubMed ID: 28622533)
1. Intrathecal IgM index correlates with a severe disease course in multiple sclerosis: Clinical and MRI results.
Ozakbas S; Cinar BP; Özcelik P; Baser H; Kosehasanoğullari G
Clin Neurol Neurosurg; 2017 Sep; 160():27-29. PubMed ID: 28622533
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal IgM synthesis in pediatric MS is not a negative prognostic marker of disease progression: quantitative versus qualitative IgM analysis.
Stauch C; Reiber H; Rauchenzauner M; Strasak A; Pohl D; Hanefeld F; Gärtner J; Rostásy KM
Mult Scler; 2011 Mar; 17(3):327-34. PubMed ID: 21123302
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal K free light chain synthesis in multiple sclerosis at clinical onset associates with local IgG production and improves the diagnostic value of cerebrospinal fluid examination.
Puthenparampil M; Altinier S; Stropparo E; Zywicki S; Poggiali D; Cazzola C; Toffanin E; Ruggero S; Grassivaro F; Zaninotto M; Plebani M; Gallo P
Mult Scler Relat Disord; 2018 Oct; 25():241-245. PubMed ID: 30130707
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis.
Villar LM; Masjuan J; González-Porqué P; Plaza J; Sádaba MC; Roldán E; Bootello A; Alvarez-Cermeño JC
Ann Neurol; 2003 Feb; 53(2):222-6. PubMed ID: 12557289
[TBL] [Abstract][Full Text] [Related]
5. Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis.
Gasperi C; Salmen A; Antony G; Bayas A; Heesen C; Kümpfel T; Linker RA; Paul F; Stangel M; Tackenberg B; Bergh FT; Warnke C; Weber F; Wiendl H; Wildemann B; Zettl UK; Ziemann U; Zipp F; Tumani H; Gold R; Hemmer B;
JAMA Neurol; 2019 Jul; 76(7):841-849. PubMed ID: 31034002
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
[TBL] [Abstract][Full Text] [Related]
7. Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis.
Kearney H; Miszkiel KA; Yiannakas MC; Altmann DR; Ciccarelli O; Miller DH
Mult Scler; 2016 Jun; 22(7):910-20. PubMed ID: 26432854
[TBL] [Abstract][Full Text] [Related]
8. The role of endogenous antiradical protective system in multiple sclerosis.
Davitashvili D; Beridze M; Shakarishvili R; Kiziria M; Sanikidze T
Georgian Med News; 2012 Apr; (205):11-9. PubMed ID: 22665726
[TBL] [Abstract][Full Text] [Related]
9. Natural history of secondary-progressive multiple sclerosis.
Tremlett H; Yinshan Zhao ; Devonshire V
Mult Scler; 2008 Apr; 14(3):314-24. PubMed ID: 18208898
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal synthesis in particular types of multiple sclerosis.
Sladkova V; Mares J; Hlustik P; Langova J; Kanovsky P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014; 158(1):124-6. PubMed ID: 23073520
[TBL] [Abstract][Full Text] [Related]
11. Increased cerebrospinal fluid chitotriosidase index in patients with multiple sclerosis.
Verbeek MM; Notting EA; Faas B; Claessens-Linskens R; Jongen PJ
Acta Neurol Scand; 2010 May; 121(5):309-14. PubMed ID: 19925532
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid IgM index correlates with cranial MRI lesion load in patients with multiple sclerosis.
Jongen PJ; Lycklama a Nijeholt G; Lamers KJ; Doesburg WH; Barkhof F; Lemmens WA; Klasen IS; Hommes OR
Eur Neurol; 2007; 58(2):90-5. PubMed ID: 17570915
[TBL] [Abstract][Full Text] [Related]
13. Intracortical excitability in patients with relapsing-remitting and secondary progressive multiple sclerosis.
Conte A; Lenzi D; Frasca V; Gilio F; Giacomelli E; Gabriele M; Bettolo CM; Iacovelli E; Pantano P; Pozzilli C; Inghilleri M
J Neurol; 2009 Jun; 256(6):933-8. PubMed ID: 19252788
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis.
Perini P; Ranzato F; Calabrese M; Battistin L; Gallo P
J Neurol Neurosurg Psychiatry; 2006 Aug; 77(8):953-5. PubMed ID: 16574727
[TBL] [Abstract][Full Text] [Related]
15. The role of oligoclonal band count and IgG index in treatment response and disease activity in multiple sclerosis.
Taşkıran E; Terzi M; Helvacı EM; Eser MZ; Avcı B; Ömer Faruk T; Yetkin MF; Çilingir V; Bir LS; Kabay SC; Bilge N; Poyraz T; Demir CF; Dündar DK; Ocak Ö; Çam M; Mavioğlu H; Altun Y; Karaibrahimoğlu A
Mult Scler Relat Disord; 2024 Mar; 83():105391. PubMed ID: 38335838
[TBL] [Abstract][Full Text] [Related]
16. Long-term evolution of multiple sclerosis disability in the treatment era.
; Cree BA; Gourraud PA; Oksenberg JR; Bevan C; Crabtree-Hartman E; Gelfand JM; Goodin DS; Graves J; Green AJ; Mowry E; Okuda DT; Pelletier D; von Büdingen HC; Zamvil SS; Agrawal A; Caillier S; Ciocca C; Gomez R; Kanner R; Lincoln R; Lizee A; Qualley P; Santaniello A; Suleiman L; Bucci M; Panara V; Papinutto N; Stern WA; Zhu AH; Cutter GR; Baranzini S; Henry RG; Hauser SL
Ann Neurol; 2016 Oct; 80(4):499-510. PubMed ID: 27464262
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal synthesis of IgM measured after a first demyelinating event suggestive of multiple sclerosis is associated with subsequent MRI brain lesion accrual.
Durante L; Zaaraoui W; Rico A; Crespy L; Wybrecht D; Faivre A; Reuter F; Malikova I; Pommier G; Confort-Gouny S; Cozzone PJ; Ranjeva JP; Pelletier J; Boucraut J; Audoin B
Mult Scler; 2012 May; 18(5):587-91. PubMed ID: 21965422
[TBL] [Abstract][Full Text] [Related]
18. CSF myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high-dose intravenous methylprednisolone.
Frequin ST; Barkhof F; Lamers KJ; Hommes OR; Borm GF
Acta Neurol Scand; 1992 Sep; 86(3):291-7. PubMed ID: 1384263
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal immunoglobulin M synthesis in multiple sclerosis. Relationship with clinical and cerebrospinal fluid parameters.
Sharief MK; Thompson EJ
Brain; 1991 Feb; 114 ( Pt 1A)():181-95. PubMed ID: 1998881
[TBL] [Abstract][Full Text] [Related]
20. MRI-detectable cortical lesions in the cerebellum and their clinical relevance in multiple sclerosis.
Favaretto A; Lazzarotto A; Poggiali D; Rolma G; Causin F; Rinaldi F; Perini P; Gallo P
Mult Scler; 2016 Apr; 22(4):494-501. PubMed ID: 26163070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]